Respiratory and antinociceptive effects of NOP-MOP agonist cebranopadol versus full opioid receptor agonist oxycodone: a comparison in healthy volunteers.

Journal:

Anesthesiology

Published:

2025-12-12

DOI:

10.1097/aln.0000000000005894

Affiliations:

6

Authors:

12

Go to article

Institutions	Authors	Share
Leiden University Medical Center (LUMC), Netherlands	4.500000	0.38
Tris Pharma, United States of America (USA)	3.000000	0.25
Centre for Human Drug Research (CHDR), Netherlands	2.833333	0.24
Amsterdam UMC, Netherlands	1.000000	0.08
Medid Consultancy B.V., Netherlands	0.333333	0.03
Outcomes Research Consortium, United States of America (USA)	0.333333	0.03

Interested in Pharmacology and Pharmaceutical Sciences?